Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Moschini

Showing results (451-460 of 561) with videos related to

Pageof 57
Sort By:
Clinical Genitourinary Cancer|June 9, 2024
Temporal Trends and Cancer-Specific Mortality in Nonmetastatic Muscle-Invasive Urothelial Carcinoma of the Urinary Bladder Treated With Trimodal TherapyMario de Angelis, Lukas Scheipner, Carolin Siech, et al.
European Urology Focus|August 29, 2021
The Value of Preoperative Plasma VEGF Levels in Urothelial Carcinoma of the Bladder Treated with Radical CystectomyKeiichiro Mori, Victor M Schuettfort, Satoshi Katayama, et al.
European Urology|August 2, 2020
Re-establishing the Role of Robot-assisted Radical Cystectomy After the 2020 EAU Muscle-invasive and Metastatic Bladder Cancer Guideline Panel RecommendationsFrancesco Montorsi, Marco Bandini, Alberto Briganti, et al.
Clinical Genitourinary Cancer|October 8, 2025
Rates of Secondary Bladder and Rectal Cancers After External Beam Radiation for Prostate Cancer According to Age and D'amico Risk Groups in A Contemporary CohortMario de Angelis, Carolin Siech, Letizia Maria Ippolita Jannello, et al.
World Journal of Urology|January 12, 2026
Second-look transurethral resection in high-grade Ta non-muscle invasive bladder cancerSophie Régnier, Pierre-Etienne Gabriel, Idir Ouzaid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2024
First Results of NURE-Combo: A Phase II Study of Neoadjuvant Nivolumab and Nab-Paclitaxel, Followed by Postsurgical Adjuvant Nivolumab, for Muscle-Invasive Bladder CancerChiara Mercinelli, Marco Moschini, Antonio Cigliola, et al.
European Urology Oncology|January 25, 2026
Risk of Recurrence and Progression After Endoscopic Kidney-sparing Surgery for Upper Tract Urothelial CarcinomaAndrea Gallioli, Francesco Di Bello, Fabio Zattoni, et al.
European Urology Oncology|October 12, 2023
A Territory-wide Study Investigating the Dose and Efficacy of Different Bacillus Calmette-Guérin Strains in Patients with Intermediate- and High-risk Non-muscle-invasive Bladder CancerKang Liu, Hongda Zhao, Xuan Chen, et al.
BJU International|August 10, 2023
Urinary function in female patients after traditional, organ-sparing and nerve-sparing radical cystectomy for bladder cancer: a systematic review and pooled analysisEkaterina Laukhtina, Markus von Deimling, Benjamin Pradere, et al.
Future Oncology (London, England)|April 27, 2026
Mitomycin for intravesical treatment of low-grade intermediate-risk non-muscle invasive bladder cancerLudovica Cella, Alessio Finocchiaro, Aleksander Ślusarczyk, et al.
Pageof 57

Showing results (451-460 of 561) with videos related to

Sort By:
Pageof 57
Clinical Genitourinary Cancer|June 9, 2024
Temporal Trends and Cancer-Specific Mortality in Nonmetastatic Muscle-Invasive Urothelial Carcinoma of the Urinary Bladder Treated With Trimodal TherapyMario de Angelis, Lukas Scheipner, Carolin Siech, et al.
European Urology Focus|August 29, 2021
The Value of Preoperative Plasma VEGF Levels in Urothelial Carcinoma of the Bladder Treated with Radical CystectomyKeiichiro Mori, Victor M Schuettfort, Satoshi Katayama, et al.
European Urology|August 2, 2020
Re-establishing the Role of Robot-assisted Radical Cystectomy After the 2020 EAU Muscle-invasive and Metastatic Bladder Cancer Guideline Panel RecommendationsFrancesco Montorsi, Marco Bandini, Alberto Briganti, et al.
Clinical Genitourinary Cancer|October 8, 2025
Rates of Secondary Bladder and Rectal Cancers After External Beam Radiation for Prostate Cancer According to Age and D'amico Risk Groups in A Contemporary CohortMario de Angelis, Carolin Siech, Letizia Maria Ippolita Jannello, et al.
World Journal of Urology|January 12, 2026
Second-look transurethral resection in high-grade Ta non-muscle invasive bladder cancerSophie Régnier, Pierre-Etienne Gabriel, Idir Ouzaid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2024
First Results of NURE-Combo: A Phase II Study of Neoadjuvant Nivolumab and Nab-Paclitaxel, Followed by Postsurgical Adjuvant Nivolumab, for Muscle-Invasive Bladder CancerChiara Mercinelli, Marco Moschini, Antonio Cigliola, et al.
European Urology Oncology|January 25, 2026
Risk of Recurrence and Progression After Endoscopic Kidney-sparing Surgery for Upper Tract Urothelial CarcinomaAndrea Gallioli, Francesco Di Bello, Fabio Zattoni, et al.
European Urology Oncology|October 12, 2023
A Territory-wide Study Investigating the Dose and Efficacy of Different Bacillus Calmette-Guérin Strains in Patients with Intermediate- and High-risk Non-muscle-invasive Bladder CancerKang Liu, Hongda Zhao, Xuan Chen, et al.
BJU International|August 10, 2023
Urinary function in female patients after traditional, organ-sparing and nerve-sparing radical cystectomy for bladder cancer: a systematic review and pooled analysisEkaterina Laukhtina, Markus von Deimling, Benjamin Pradere, et al.
Future Oncology (London, England)|April 27, 2026
Mitomycin for intravesical treatment of low-grade intermediate-risk non-muscle invasive bladder cancerLudovica Cella, Alessio Finocchiaro, Aleksander Ślusarczyk, et al.
Pageof 57